(Q51580604)

7 April 2018

title

Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists. (English)

1 reference

7 April 2018

author name string

Grant KA

1

1 reference

7 April 2018

Colombo G

2

1 reference

7 April 2018

Grant J

3

1 reference

7 April 2018

Rogawski MA

4

1 reference

7 April 2018

publication date

1 January 1996

1 reference

7 April 2018

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

7 April 2018

volume

35

1 reference

7 April 2018

issue

12

1 reference

7 April 2018

page(s)

1709-1719

1 reference

7 April 2018

Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Biochemical and behavioral effects of sigma and PCP ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Interaction of phencyclidine with voltage-dependent potassium channels in cultured rat hippocampal neurons: comparison with block of the NMDA receptor-ionophore complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Memantine in the treatment of senile dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Differentiation of [3H]phencyclidine and (+)-[3H]SKF-10,047 binding sites in rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

ARL-15896, a novel N-methyl-D-aspartate receptor ion channel antagonist: neuroprotection against mitochondrial metabolic toxicity and regional pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Discriminative stimulus effects of dextromethorphan in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Effects of anticonvulsants in a novel operant learning paradigm in rats: comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Behavioral and electrophysiological comparison of ketamine with dizocilpine in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Discriminative stimulus properties of phencyclidine (PCP)-related compounds: correlations with 3H-PCP binding potency measured autoradiographically.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Phencyclidine receptors in rat brain cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Newer antiepileptic drugs. Towards an improved risk-benefit ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Phencyclidine (PCP): some human studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Pharmacotoxic psychosis after memantine in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Anticonvulsant efficacy of ADCI (5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine) after acute and chronic dosing in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Dextromethorphan and carbetapentane: centrally acting non-opioid antitussive agents with novel anticonvulsant properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Phencyclidine-like discriminative stimulus properties of MK-801 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidine-trained rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

The behavioral pharmacology of NMDA receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

Quantitation of the novel anticonvulsant remacemide in rat and dog plasma and urine: application of the plasma methodology to measure the plasma protein binding of remacemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900147-5

10.1016/S0028-3908(96)00147-5

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018